Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Clinical trial NCT00247572 · COMPLETED

Trial details

NCT number: NCT00247572
Sponsor: New River Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Amphetamine-Related Disorders Substance-Related Disorders

Start date: 2005-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.